SantheraSantheraNew CCO starts in JuneMarc Clausse will take up his new role as Chief Commercial Officer at Santhera Pharmaceuticals (SIX: SANN) at the beginning of June. He succeeds Geert Jan van Daal, who is retiring. more ➔
AC Immune SAAC ImmuneCo-founder and CEO steps downDr Andrea Pfeifer, long-serving CEO and co-founder from AC Immune, has decided to retire. AC Immune’s Board of Directors has appointed the Chair, Dr Martin Zügel, to serve as interim CEO while the … more ➔
Resyca BVResyca BVNext stage of growth with a new CEODr Deborah Jones joined the Dutch Resyca BV as CEO at the beginning of April, succeeding Remko Beimers, who has stepped down from his role. more ➔
AnaveonAnaveonLeadership changeSwiss biotech company Anaveon has appointed a new Chief Executive Officer. As the company announced in March, experienced biopharma executive Thaminda Ramanayake will take over the leadership of the … more ➔
NovartisNovartisNew CFO with Novartis experienceIn March, Mukul Mehta took over as the new Chief Financial Officer at Basel-based Biotech and Pharma Company Novartis. At the same time, he became a member of the Executive Committee. more ➔
eXmoor PharmaeXmoor Pharma LtdNew CCO strengthens global business strategyBristol-based cell and gene therapy CDMO eXmoor Pharma appointed Manuel Balbuena as Chief Commercial Officer at the beginning of March. more ➔
SymeresSymeresReturn as new Chief Financial OfficerJurgen Berendsen has returned to Symeres (Nijmegen, NL) as Chief Financial Officer. His appointment took place at the beginning of this year. more ➔
Qureight LtdQureightNew COO takes overCambridge-based techbio company Qureight Ltd has appointed Rebecca Simmons as its new Chief Operating Officer in January. more ➔
WLan HoldingFairJourney BiologicsNew CEO strengthens managementFairJourney Biologics (Porto, PT) has appointed Dr Werner Lanthaler, long-standing Evotec CEO, as Chief Executive Officer. Founder António Parada will focus on innovation strategy on the Supervisory … more ➔
Julius ClinicalJulius ClinicalNew CEO takes overContract Research Organization Julius Clinical (NL) appointed Bassem Saleh as its new Chief Executive Officer. His predecessor, Martijn Wallert, will become an advisor to the Executive Board. more ➔
Santhera
AC Immune SA
Resyca BV
Anaveon
Novartis
eXmoor Pharma
Symeres
Qureight Ltd
WLan Holding
Julius Clinical